Hypofractionated Stereotactic Radiotherapy in Recurrent Glioblastoma Multiforme

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

July 31, 2021

Study Completion Date

August 31, 2024

Conditions
Recurrent Glioblastoma Multiforme
Interventions
RADIATION

Stereotactic hypofractionated RT 5x5Gy

"Stereotactic hypofractionated radiation therapy delivered as follows:~* Gross tumor volume (GTV) equals enhancement area in T1 contrast enhanced MRI.~* Planning tumor volume (PTV) equals GTV plus 3mm margin.~* The dose of radiation will be 25Gy delivered in 5 fractions.1 fraction per day, non consecutive days in a maximum period of 10 working days.~* RT to begin in a maximum of 2 weeks after randomization"

RADIATION

Stereotactic hypofractionated RT 5x7Gy

"Stereotactic hypofractionated radiation therapy delivered as follows:~* Gross tumor volume (GTV) equals enhancement area in T1 contrast enhanced MRI.~* Planning tumor volume (PTV) equals GTV plus 3mm margin.~* The dose of radiation will be 35Gy delivered in 5 fractions.1 fraction per day, non consecutive days in a maximum period of 10 working days.~* RT to begin in a maximum of 2 weeks after randomization."

Trial Locations (1)

05403-010

Hospital das Clinicas da Faculdade de Medicina da USP, São Paulo

All Listed Sponsors
lead

Andre Tsin Chih Chen

OTHER

NCT01464177 - Hypofractionated Stereotactic Radiotherapy in Recurrent Glioblastoma Multiforme | Biotech Hunter | Biotech Hunter